How to Keep Weight Off After Stopping Wegovy

You've stopped Wegovy. Here's what's happening in your body right now

Picture this: you finished your last Wegovy pen three weeks ago, and you're already noticing that familiar pull towards the biscuit tin at 11pm. That's not a failure of willpower. When semaglutide leaves your system, the GLP-1 receptor stimulation that was slowing gastric emptying and moderating appetite signals drops away. Hunger hormones, including ghrelin, begin reasserting themselves. The biological environment that made eating less feel manageable starts to reverse.

The STEP 1 trial extension data quantified this clearly: participants who stopped semaglutide regained, on average, two-thirds of their lost weight within a year. That figure comes from a controlled research setting, and the broader STEP trial findings on semaglutide withdrawal and weight regain show that real-world outcomes vary, but the direction is consistent. It is also why the NHS guidance on semaglutide is explicit that weight management continues to need attention after treatment ends. The drug was doing some of the heavy lifting. When it stops, that work has to come from elsewhere.

The timeline matters too. Weight regain tends to begin quite quickly after the last dose, often within weeks. Knowing that early window is the highest-risk period helps you plan ahead rather than react once the pattern has already set in.

The habits that actually protect your weight after Wegovy ends

The treatment window is an opportunity to build infrastructure. People who use the appetite reduction that Wegovy provides to genuinely reshape their eating patterns (not just eat less of the same things) tend to fare better after stopping. Protein intake is the single most evidence-supported dietary lever: higher protein meals slow gastric emptying naturally and preserve lean muscle mass during weight loss, and that muscle is metabolically valuable when treatment ends.

Resistance exercise matters for the same reason. Cardio burns calories; resistance training builds or maintains the muscle tissue that keeps resting metabolic rate from dropping as sharply as it otherwise would. If you only walked during treatment, adding two sessions of bodyweight or weight-bearing exercise per week before you stop is worth discussing with your clinical team.

Sleep and stress are frequently underestimated. Poor sleep drives cortisol and ghrelin; chronic stress does the same. These aren't lifestyle platitudes, they are measurable physiological inputs to the same system that Wegovy was modulating. Addressing them is part of the same problem. The NHS Better Health lose weight guidance covers the behavioural side of weight management in plain language and is worth bookmarking alongside your clinical support.

One practical anchor: many people on weekly injections get into the habit of keeping their pen in the fridge door and reviewing how the week felt before their next dose. That same moment (a brief weekly check-in with your own eating, activity and sleep) is worth preserving after treatment ends, even without the pen. Structure beats motivation every time.

Should you taper off, pause, or stay on a lower dose?

This is the question our prescribers hear most often in the months before someone plans to stop. There is no single right answer, and anyone who tells you there is hasn't read the evidence carefully.

Tapering (reducing dose gradually rather than stopping abruptly) is one approach some clinicians recommend to give the body time to adjust. The data on whether tapering materially changes long-term weight outcomes is not yet definitive, but it can ease the transition in terms of appetite and GI symptoms. How you come off Wegovy matters, and that decision should be made with a prescriber who knows your dose history and health picture.

Staying on a maintenance dose, if clinically appropriate, is another option. NICE's guidance acknowledges that obesity is a chronic condition and that for some people treatment may need to be long-term. That framing is worth sitting with: we don't expect someone with a chronic condition to stop their medicine and then manage without support. The equivalent conversation in weight management is still catching up.

If you're weighing up what happens next with your treatment, a full overview of Wegovy covers the licensed details, and how long it takes for weight to return after stopping semaglutide gives you the timeline evidence in more detail. The right next step is a conversation with a prescriber, not a decision made alone on the basis of how you feel in week three.

What a prescriber can do that a plan alone cannot

A prescriber can look at your weight trajectory, your dose history, any comorbidities, and your circumstances and tell you whether continuing, tapering, or stopping is the right call for you specifically. They can also flag if weight regain is happening at a rate that warrants restarting treatment, which NICE guidance supports in appropriate cases.

At nume, a real clinician reviews every repeat order and every request to change or stop treatment before anything is actioned. If you're approaching the end of a course and uncertain what comes next, that's exactly the kind of conversation our clinical team is here for. You can also explore the broader weight-loss treatment options if your circumstances have changed since you started. Speak to our prescribers through a free consultation, it costs nothing to get a clinical view before you decide.